Literature DB >> 32163719

Cost, Hassle, and On-Body Experience: Barriers to Diabetes Device Use in Adolescents and Potential Intervention Targets.

Laurel H Messer1, Molly L Tanenbaum2, Paul F Cook3, Jessie J Wong2, Sarah J Hanes2, Kimberly A Driscoll4, Korey K Hood2.   

Abstract

Background: Adolescents with diabetes have the highest A1cs of all age groups. Diabetes devices (insulin pumps and continuous glucose monitors [CGM]) can improve glycemic outcomes, and although the uptake of devices has increased, they remain underutilized in this population. This study characterizes adolescent-reported barriers to diabetes device use to determine targets for clinician intervention.
Methods: We surveyed 411 adolescents with type 1 diabetes (mean age 16.30 ± 2.25 years) on barriers to diabetes device use, technology use attitudes (general and diabetes specific), benefits and burdens of CGM, self-efficacy for diabetes care, diabetes distress, family conflict, and depression. We characterize barriers to device uptake; assess demographic and psychosocial differences in device users, discontinuers, and nonusers; and determine differences in device use by gender and age.
Results: The majority of adolescents used an insulin pump (n = 307, 75%) and more than half used CGM (n = 225, 55%). Cost/insurance-related concerns were the most commonly endorsed barrier category (61%) followed by wear-related issues (58.6%), which include the hassle of wearing the device (38%) and dislike of device on the body (33%). Adolescents who endorsed more barriers also reported more diabetes distress (P = 0.003), family conflict (P = 0.003), and depressive symptoms (P = 0.014). Pump and CGM discontinuers both endorsed more barriers and more negative perceptions of technology than current users, but reported no difference from device users in diabetes distress, family conflict, or depression. Gender was not related to the perceptions of devices. Conclusions: Clinicians can proactively assess attitudes toward diabetes technology and perceptions of benefits/burdens to encourage device uptake and potentially prevent device discontinuation among adolescents.

Entities:  

Keywords:  Adolescents; Continuous glucose monitoring; Diabetes technology; Insulin pump; Type 1 diabetes

Year:  2020        PMID: 32163719     DOI: 10.1089/dia.2019.0509

Source DB:  PubMed          Journal:  Diabetes Technol Ther        ISSN: 1520-9156            Impact factor:   6.118


  18 in total

1.  Help when you need it: Perspectives of adults with T1D on the support and training they would have wanted when starting CGM.

Authors:  Molly L Tanenbaum; Laurel H Messer; Christine A Wu; Marina Basina; Bruce A Buckingham; Danielle Hessler; Shelagh A Mulvaney; David M Maahs; Korey K Hood
Journal:  Diabetes Res Clin Pract       Date:  2021-09-14       Impact factor: 8.180

2.  'I was ready for it at the beginning': Parent experiences with early introduction of continuous glucose monitoring following their child's Type 1 diabetes diagnosis.

Authors:  Molly L Tanenbaum; Dessi P Zaharieva; Ananta Addala; Jessica Ngo; Priya Prahalad; Brianna Leverenz; Christin New; David M Maahs; Korey K Hood
Journal:  Diabet Med       Date:  2021-04-21       Impact factor: 4.359

Review 3.  Advances, Challenges, and Cost Associated with Continuous Glucose Monitor Use in Adolescents and Young Adults with Type 1 Diabetes.

Authors:  Karishma A Datye; Daniel R Tilden; Angelee M Parmar; Eveline R Goethals; Sarah S Jaser
Journal:  Curr Diab Rep       Date:  2021-05-15       Impact factor: 4.810

4.  Perceived Burdens and Benefits Associated With Continuous Glucose Monitor Use in Type 1 Diabetes Across the Lifespan.

Authors:  Vidita Divan; Margaret Greenfield; Christopher P Morley; Ruth S Weinstock
Journal:  J Diabetes Sci Technol       Date:  2020-12-24

5.  Technological Ecological Momentary Assessment Tools to Study Type 1 Diabetes in Youth: Viewpoint of Methodologies.

Authors:  Mary Katherine Ray; Alana McMichael; Maria Rivera-Santana; Jacob Noel; Tamara Hershey
Journal:  JMIR Diabetes       Date:  2021-06-03

6.  First Outpatient Evaluation of a Tubeless Automated Insulin Delivery System with Customizable Glucose Targets in Children and Adults with Type 1 Diabetes.

Authors:  Gregory P Forlenza; Bruce A Buckingham; Sue A Brown; Bruce W Bode; Carol J Levy; Amy B Criego; R Paul Wadwa; Erin C Cobry; Robert J Slover; Laurel H Messer; Cari Berget; Susan McCoy; Laya Ekhlaspour; Ryan S Kingman; Mary K Voelmle; Jennifer Boyd; Grenye O'Malley; Aimee Grieme; Kaisa Kivilaid; Krista Kleve; Bonnie Dumais; Todd Vienneau; Lauren M Huyett; Joon Bok Lee; Jason O'Connor; Eric Benjamin; Trang T Ly
Journal:  Diabetes Technol Ther       Date:  2021-01-18       Impact factor: 6.118

Review 7.  Artificial Pancreas Technology Offers Hope for Childhood Diabetes.

Authors:  Melissa J Schoelwer; Mark D DeBoer
Journal:  Curr Nutr Rep       Date:  2021-01-07

Review 8.  Products for Monitoring Glucose Levels in the Human Body With Noninvasive Optical, Noninvasive Fluid Sampling, or Minimally Invasive Technologies.

Authors:  Trisha Shang; Jennifer Y Zhang; Andreas Thomas; Mark A Arnold; Beatrice N Vetter; Lutz Heinemann; David C Klonoff
Journal:  J Diabetes Sci Technol       Date:  2021-06-13

9.  Real-World Use of a New Hybrid Closed Loop Improves Glycemic Control in Youth with Type 1 Diabetes.

Authors:  Laurel H Messer; Cari Berget; Laura Pyle; Timothy Vigers; Erin Cobry; Kimberly A Driscoll; Gregory P Forlenza
Journal:  Diabetes Technol Ther       Date:  2021-06-21       Impact factor: 6.118

10.  Diabetes Technology Meeting 2020.

Authors:  Trisha Shang; Jennifer Y Zhang; B Wayne Bequette; Jennifer K Raymond; Gerard Coté; Jennifer L Sherr; Jessica Castle; John Pickup; Yarmela Pavlovic; Juan Espinoza; Laurel H Messer; Tim Heise; Carlos E Mendez; Sarah Kim; Barry H Ginsberg; Umesh Masharani; Rodolfo J Galindo; David C Klonoff
Journal:  J Diabetes Sci Technol       Date:  2021-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.